B.
TNF-α inhibitors is called as game changer in autoimmune diseases because, In a autoimmune diseases there is increase in TNF-α at the head of cytokine which leads to inflammation, TNF-α inhibitiors binds with TNF-α and controls the symptoms, with low side effects.
TNF-α inhibitors target central inflammatory pathway and substantially reduce symptoms, prevent irreversible damage, and restore function in several autoimmune diseases. They are thus considered as Game changers in autoimmune diseases.
Ans is TNF alpha
“Insightful explanation, thanks for sharing! 
”
Infliximab is a monoclonal antibody that binds to and neutralizes.
TNF-@
By blocking tumor necrosis factor-alpha (TNF-α), a protein that causes inflammation, it reduces pain, swelling, and tissue damage. Crohn’s disease basically is a inflammatory disease, so infliximab works well with it by reducing inflammation.
TNF-α is a major driver of chronic inflammation in autoimmune diseases. By specifically blocking this cytokine, infliximab helps reduce inflammation, promote tissue healing, and improve symptoms, making TNF-α inhibitors a true game changer in conditions like Crohn’s disease, rheumatoid arthritis, and psoriasis